ToxOmics, NOVA Medical School, Faculdade de Ciências Médicas, NMSFCM, Universidade NOVA de Lisboa, Lisbon, Portugal.
CIC biomaGUNE, Basque Research and Technology Alliance (BRTA), 20014, Donostia-San Sebastián, Spain.
Drug Deliv Transl Res. 2024 Aug;14(8):2262-2275. doi: 10.1007/s13346-024-01533-w. Epub 2024 Feb 20.
Due to the severity and high prevalence of cancer, as well as its complex pathological condition, new strategies for cancer treatment and diagnostics are required. As such, it is important to design a toolbox that integrates multiple functions on a single smart platform. Theranostic hydrogels offer an innovative and personalized method to tackle cancer while also considering patient comfort, thereby facilitating future implementation and translation to the clinic. In terms of theranostic systems used in cancer therapy, nanoparticles are widely used as diagnostic and therapeutic tools. Nanoparticles can achieve systemic circulation, evade host defenses, and deliver drugs and signaling agents at the targeted site, to diagnose and treat the disease at a cellular and molecular level. In this context, hydrogel microneedles have a high potential for multifunctional operation in medical devices, while avoiding the complications associated with the systemic delivery of therapeutics. Compared with oral administration and subcutaneous injection, microneedles offer advantages such as better patient compliance, faster onset of action, and improved permeability and efficacy. In addition, they comprise highly biocompatible polymers with excellent degradability and tunable properties. Nanoparticles and microneedles thus offer the possibility to expand the theranostic potential through combined synergistic use of their respective features. We review herein recent advances concerning processing methods and material requirements within the realm of hydrogel microneedles as theranostic platforms, various approaches toward cancer therapy, and the incorporation of nanoparticles for added functionality.
由于癌症的严重性和高发性,以及其复杂的病理状况,需要新的癌症治疗和诊断策略。因此,设计一个集成多种功能于单一智能平台的工具包非常重要。治疗性水凝胶为解决癌症问题提供了一种创新和个性化的方法,同时考虑到患者的舒适度,从而促进了未来在临床中的实施和转化。在癌症治疗中使用的治疗系统方面,纳米粒子被广泛用作诊断和治疗工具。纳米粒子可以实现全身循环,逃避宿主防御,并在靶向部位递送药物和信号剂,从而在细胞和分子水平上诊断和治疗疾病。在这种情况下,水凝胶微针在医疗器械的多功能操作方面具有很高的潜力,同时避免了与全身递送治疗剂相关的并发症。与口服和皮下注射相比,微针具有更好的患者依从性、更快的作用开始时间以及改善的通透性和疗效等优势。此外,它们由具有优异可降解性和可调特性的高度生物相容性聚合物组成。因此,纳米粒子和微针通过联合利用各自的特点,为扩大治疗潜力提供了可能。本文综述了水凝胶微针作为治疗平台的处理方法和材料要求方面的最新进展,各种癌症治疗方法,以及为增加功能而结合使用纳米粒子的方法。
Drug Deliv Transl Res. 2024-8
Adv Sci (Weinh). 2025-1-30
Arch Ital Urol Androl. 2025-6-30
2025-1
Front Cell Dev Biol. 2025-7-25
Crit Rev Ther Drug Carrier Syst. 2025
Cochrane Database Syst Rev. 2022-4-26
Front Oncol. 2025-4-17
Clin Rev Allergy Immunol. 2025-3-18
Pharmaceuticals (Basel). 2024-6-16
J Am Chem Soc. 2024-1-17
J Pharm Pharmacol. 2023-8-1
Biomed Microdevices. 2023-6-6
Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2023
Nat Mater. 2023-7
Biomacromolecules. 2023-3-13
Drug Deliv Transl Res. 2023-6
Nat Rev Drug Discov. 2023-3